Akèy › Dematit atopik (Ekzema) › Kalifòni › Los Angeles
Etid klinik pou Dematit atopik (Ekzema) nan Los Angeles, CA
11 etid pou Dematit atopik (Ekzema) ap chèche patisipan nan sit nan ak bò kote Los Angeles (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Ap rekriteEtid obsèvasyon
- Dermatology Research Associates - Los Angeles- Site Number : 8400020, Los Angeles
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Ap rekriteFaz 2
- Novartis Investigative Site, Los Angeles
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Ap rekriteFaz 2
- Metropolis Dermatology - DTLA, Los Angeles
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Ap rekriteFaz 2
- Investigational Site, Los Angeles
A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
Ap rekriteFaz 2
- UCLA Division of Dermatology, Los Angeles
- Dermatology Research Associate, Los Angeles
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Ap rekriteFaz 2
- Metropolis Dermatology, Los Angeles
- Dermatology Research Associates, Los Angeles
- University of California Los Angeles, Los Angeles
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Ap rekriteFaz 2
- Inmagene Site 23, Los Angeles
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Ap rekriteFaz 2
- Enveda Investigative Site, Los Angeles
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
Ap rekriteFaz 2
- California Allergy and Asthma Medical Group, Los Angeles
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Ap rekriteFaz 2
- California Allergy and Asthma Medical Group, Los Angeles
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Ap rekriteEtid obsèvasyon
- Galderma Investigational Site 7099, Los Angeles
Etid Dematit atopik (Ekzema) nan lòt vil
- New York City, NY13 etid
- Washington, DC11 etid
- San Antonio, TX10 etid
- San Diego, CA10 etid
- Birmingham, AL9 etid
- Miami, FL9 etid
- Dallas, TX8 etid
- Huntington Beach, CA8 etid
- Sacramento, CA8 etid
- Troy, MI8 etid
- Indianapolis, IN7 etid
- Tampa, FL7 etid
Lòt etid nan Los Angeles
- Kansè Poumon ki pa ti selil87 etid
- Kansè (tout kalite)74 etid
- Kansè nan tete73 etid
- Kansè pwostat61 etid
- Kansè kolorektal59 etid
- Kansè Metastatik57 etid
- Kansè ovè50 etid
- Kansè poumon45 etid
- Karsinòm selil skuamèz tèt ak kou42 etid
- Kansè pankreyas35 etid
- Kansè Endomèt34 etid
- Melanom34 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.